Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 14/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.61 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.61 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.57 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.57 |
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5040384 | 0.93 | ADORA1 (0.61) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5034068 | 0.92 | ADORA3 (0.59) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL5034070 | 0.91 | ADORA3 (0.58) | ADORA1ADORA3ADORA2AADORA2BMEN1 | |
| SCHEMBL5034049 | 0.88 | ADORA1 (0.56) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5032115 | 0.88 | ADORA1 (0.56) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5034075 | 0.87 | ADORA1 (0.55) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5034543 | 0.87 | ADORA1 (0.58) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5034048 | 0.87 | ADORA1 (0.55) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5032136 | 0.85 | ADORA1 (0.65) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 | |
| SCHEMBL5034493 | 0.84 | ADORA1 (0.61) | ADORA1ADORA3ADORA2AADORA2BSLC28A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1881991-A1 | A1 ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2008-01-30 | — | — | EP | claimed |
| WO-2006125211-A1 | A1 ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2006-11-23 | — | — | WO | claimed |
| EP-1881991-A1 | A1 ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2008-01-30 | — | — | EP | disclosed |
| WO-2006125211-A1 | A1 ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2006-11-23 | — | — | WO | disclosed |